New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
60 Degrees Pharmaceuticals, Inc.
SXTP
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4M

Biotechnology

Next Earning date - 13 Aug 2025

4M

Biotechnology

Next Earning date - 13 Aug 2025

2.62USD

Shape0.01 ( 0.38%)
Market Open
favorite-chart

Relative Strenght

82
favorite-chart

Volume Buzz

-87%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

93%

Quote Panel

Shape
Updated July 11, 2025
1W 12.45 % 1M 14.91 % 3M -19.63 % 1Y -82.21 %

Key Metrics

Shape
  • Market Cap

    3.86M


  • Shares Outstanding

    1.47M


  • Share in Float

    1.37M


  • Dividende

    0


  • Earning Date

    13 Aug 2025


  • Price Target

    2.62


  • Average Volume

    197926


  • Beta

    -0.8776657


  • Range

    1.41-36


  • Industry

    Biotechnology


  • Website

    https://60degreespharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.87x

P/S Ratio

0.81x

P/B Ratio

0.0

Debt/Equity

-1564.6%

Net Margin

$-21.9

EPS

How SXTP compares to sector?

P/E Ratio

Relative Strength

Shape

SXTP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape1349%

2026-Revenue

$3.04

Shape-95%

2026-EPS

$2M

Shape-0%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-1.40
vs -0.39

Q3.23

arrow
arrow

N/A

-18.01
vs -0.26

Q4.23

arrow
arrow

N/A

-0.34
vs -0.35

Q1.24

arrow
arrow

N/A

-26.41
vs -0.47

Q2.24

arrow
arrow

N/A

-21.15
vs -1.40

Q3.24

arrow
arrow

N/A

-4.65
vs -18.01

Q4.24

arrow
arrow

N/A

-14.20
vs -0.34

Q1.25

arrow
arrow

N/A

-1.56
vs -26.41

Q2.25

arrow
arrow

N/A

-0.96
vs -21.15

Q3.25

arrow
arrow

N/A

-0.83
vs -4.65

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

+32%

59.5K  vs 45.2K

Q3.23

arrow
arrow

-70%

51.2K  vs 168.2K

Q4.23

arrow
arrow

+156%

42.7K  vs -75652

Q1.24

arrow
arrow

+751%

146.1K  vs 17.2K

Q2.24

arrow
arrow

+111%

125.7K  vs 59.5K

Q3.24

arrow
arrow

+164%

135.3K  vs 51.2K

Q4.24

arrow
arrow

+441%

230.8K  vs 42.7K

Q1.25

arrow
arrow

+12%

163.6K  vs 146.1K

Q2.25

arrow
arrow

+226%

410K  vs 125.7K

Q3.25

arrow
arrow

+225%

440K  vs 135.3K

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+15%

0.15
vs 0.14

Q3.23

arrow
arrow

+64%

0.64
vs 0.15

Q4.23

arrow
arrow

-41%

-0.41
vs 0.64

Q1.24

arrow
arrow

+6%

0.06
vs -0.41

Q2.24

arrow
arrow

-137%

-1.37
vs 0.06

Q3.24

arrow
arrow

-36%

-0.36
vs -1.37

Q4.24

arrow
arrow

-51%

-0.51
vs -0.36

Q1.25

arrow
arrow

-46%

-0.46
vs -0.51

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News